Exact Mass: 273.1528842

beta-Erythroidine

β-Erythroidine

An organic heterotetracyclic indole alkaloid isolated from the seeds and other parts of Erythrina species. It differs from the alpha isomer in having the double bond of the dihydropyranone ring located beta,gamma- to the lactone carbonyl group instead of alpha,beta-.

Lunacrine

8-Allyl-2-phenyl-8H-1,3a,8-triaza-cyclopenta[a]indene

C18H15N3 (273.126591)

Norgalantamine

(-)-N-Demethylgalanthamine

N-Desmethyl Galanthamine is a metabolite of Galanthamine. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM[1][2].

Normaritidine

(-)-8-Demethylmaritidine

Sanguinine

(1S,12S,14R)-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraene-9,14-diol

Sanguinine is a benzazepine. Sanguinine is a natural product found in Lycoris sanguinea, Lycoris squamigera, and other organisms with data available. O-Desmethyl Galanthamine (Sanguinine) is galanthamine-type alkaloid. O-Desmethyl Galanthamine is an acetylcholinesterase (AChE) inhibitor, with an IC50 1.83 μM[1].

N-Desmethylzolmitriptan

N-Desmethyl Zolmitriptan

(2R,3R)-3-Methylglutamyl-5-semialdehyde-N6-lysine

Tabtoxin biosynthesis intermediate 6

C20916; Tabtoxin biosynthesis intermediate 6

Macowine

4-O-Methylnorbelladine

5-[[2-(4-hydroxyphenyl)ethylamino]methyl]-2-methoxy-phenol

A phenethylamine alkaloid that is norbelladine in which the phenolic hydrogen at position 4 has been replaced by a methyl group.

(E,E)-Piperlonguminine

(Z,2E,4E)-5-(2H-1,3-benzodioxol-5-yl)-N-(2-methylpropyl)penta-2,4-dienimidic acid

(E,E)-Piperlonguminine is a member of benzodioxoles. Piperlonguminine is a natural product found in Piper amalago, Piper retrofractum, and other organisms with data available. (E,E)-Piperlonguminine is found in herbs and spices. (E,E)-Piperlonguminine is an alkaloid from Piper longum (long pepper) and other Piper specie Alkaloid from Piper longum (long pepper) and other Piper subspecies (E,E)-Piperlonguminine is found in herbs and spices. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4]. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4].

(2E)-Piperamide-C5:1

(2E)-5-(2H-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

(2E)-Piperamide-C5:1 is found in herbs and spices. (2E)-Piperamide-C5:1 is a constituent of pepper fruits (Piper nigrum, Piperaceae). Constituent of pepper fruits (Piper nigrum, Piperaceae). (2E)-Piperamide-C5:1 is found in herbs and spices and pepper (spice).

Valylarginine

(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanoic acid

Valylarginine is a dipeptide composed of valine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Arginylvaline

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanoic acid

Arginylvaline is a dipeptide composed of arginine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Glutaconylcarnitine

(3S)-3-{[(2E)-4-carboxybut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

Glutaconylcarnitine is an acylcarnitine. More specifically, it is an glutaconic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Glutaconylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine glutaconylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

Heptanoylcarnitine

3-(heptanoyloxy)-4-(trimethylazaniumyl)butanoate

Heptanoylcarnitine is an acylcarnitine. More specifically, it is an heptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Heptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine heptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

Linalyl anthranilate

Anthranilic acid, 1, 5-dimethyl-1-vinyl-4-hexenyl ester

Linalyl anthranilate is used in food flavourin It is used in food flavouring.

alpha-Terpinyl anthranilate

2-(4-Methylcyclohex-3-en-1-yl)propan-2-yl 2-aminobenzoic acid

alpha-Terpinyl anthranilate is a flavouring ingredient with a complex fruity odour and bitter taste. Flavouring ingredient with a complex fruity odour and bitter taste

N-Despropyl-rotigotine

6-{[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol

C16H19NOS (273.1187284)

N-Despropyl-rotigotine is a metabolite of rotigotine. Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinsons disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well. (Wikipedia)

N-Acetyl desmethyl frovatriptan

3-acetamido-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide

N-Acetyl desmethyl frovatriptan is a metabolite of frovatriptan. Frovatriptan (trade name Frova) is a triptan drug developed by Vernalis for the treatment of migraine headaches and for short term prevention of menstrual migraine. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe. (Wikipedia)

4-Methylhexanoylcarnitine

3-[(4-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

4-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

5-Methylhexanoylcarnitine

3-[(5-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

5-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

3-Methylhexanoylcarnitine

3-[(3-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

3-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

(3E)-Glutaconylcarnitin

3-[(4-carboxybut-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

(3E)-Glutaconylcarnitin is an acylcarnitine. More specifically, it is an (3E)-pent-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3E)-Glutaconylcarnitin is therefore classified as a short chain AC. As a short-chain acylcarnitine (3E)-Glutaconylcarnitin is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

(4E)-3-Hydroxyhex-4-enoylcarnitine

3-[(3-hydroxyhex-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

(4E)-3-hydroxyhex-4-enoylcarnitine is an acylcarnitine. More specifically, it is an (4E)-3-hydroxyhex-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4E)-3-hydroxyhex-4-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (4E)-3-hydroxyhex-4-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

3-Oxohexanoylcarnitine

3-[(3-oxohexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

3-oxohexanoylcarnitine is an acylcarnitine. More specifically, it is an 3-oxohexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-oxohexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-oxohexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

5-Oxohexanoylcarnitine

3-[(5-oxohexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

5-oxohexanoylcarnitine is an acylcarnitine. More specifically, it is an 5-oxohexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-oxohexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-oxohexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

4-Methylpropranolol

1-[(4-methylnaphthalen-1-yl)oxy]-3-[(propan-2-yl)amino]propan-2-ol

C11H16FN3O4 (273.11247879999996)

Hhcfu

5-fluoro-N-(5-hydroxyhexyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-carboxamide

Desmethylcyproheptadine

4-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-ylidene}piperidine

Dextilidine

Ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylic acid

Mopidralazine

N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(morpholin-4-yl)pyridazin-3-amine

C14H19N5O (273.1589524)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent

N-Desmethyl zolmitriptan

4-({3-[2-(methylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one

N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-toluidine

3-[ethyl(3-methylphenyl)amino]-2-hydroxypropane-1-sulfonic acid

Norgalanthamine

9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-ol

Prodolic acid

Pyrano[3,4-b]indole-1-aceticacid, 1,3,4,9-tetrahydro-1-propyl-

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

indole-3-acetyl-valine

2-[2-(1H-indol-3-yl)acetamido]-3-methylbutanoate

C15H17N2O3- (273.1239112)

Indole-3-acetyl-valine is also known as iaa-val. Indole-3-acetyl-valine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-valine can be found in a number of food items such as avocado, cupua√ßu, green bean, and guava, which makes indole-3-acetyl-valine a potential biomarker for the consumption of these food products. Indole-3-acetyl-valine is also known as iaa-val. Indole-3-acetyl-valine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-valine can be found in a number of food items such as avocado, cupuaçu, green bean, and guava, which makes indole-3-acetyl-valine a potential biomarker for the consumption of these food products.

Valyl-Arginine

2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-5-carbamimidamidopentanoic acid

9-Norpluviine

9-O-Demethylpluviine

8-O-Demethylvasconine

(-)-8-Demethylmaritidine

SCHEMBL22342125

metazachlor OXA

A monocarboxylic acid that is oxoacetic acid substituted by a (2,6-dimethylphenyl)(1H-pyrazol-1-ylmethyl)amino group at position 2. It is metabolite of the herbicide metazachlor. CONFIDENCE standard compound; EAWAG_UCHEM_ID 706 CONFIDENCE standard compound; INTERNAL_ID 2062

Ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate

4-(Phenylazo)diphenylamine

C18H15N3 (273.126591)

N-(4-fluorophenyl)adamantane-1-carboxamide

C17H20FNO (273.1528842)

Oprea1_355724

Maybridge3_005694

DTXSID90891601

CHEMBL501839

methyl isoplatydesmine

cocculine

10-Methoxy-3,12-didehydrogalanthan-1,9-diol #

8-O-demethylmaritidine|9-O-Demethylmaritidine

DTXSID60556811

N-isobutyl-6-(p-methoxyphenyl)hexa-3,5-dienamide

4-O-Demethylmesembrenon|4-O-Demethylmesembrenone

lorneamide A

Dihydrocrinine

Sedacrine

1-Methyl-8-methoxy-2-hexylquinolin-4(1H)-one

glycolone

1,2-O-Isopropylidene,N,5-Di-Ac-alpha-D-Furanose-3-Amino-3-deoxyribose

(2E,4E,6E)-7-(2-thienyl)-2,4-6-heptatrienoic acid piperidide|1-[(2E,4E,6E)-1-oxo-7-(2-thienyl)heptatrienyl]piperidine|1-[(2E,4E,6E)-7-(2-thienyl)-2,4,6-heptatrienoyl]piperidine|7-(thiophene)-2E,4E,6E-heptatrienoic acid piperidide|N-piperidineotanthusic acid amide|Otanthus acid piperidide|Otanthus Maritima amide|Otanthussaeure-piperidid

(2E,4E,6E)-7-(2-thienyl)-2,4-6-heptatrienoic acid piperidide|1-[(2E,4E,6E)-1-oxo-7-(2-thienyl)heptatrienyl]piperidine|1-[(2E,4E,6E)-7-(2-thienyl)-2,4,6-heptatrienoyl]piperidine|7-(thiophene)-2E,4E,6E-heptatrienoic acid piperidide|N-piperidineotanthusic acid amide|Otanthus acid piperidide|Otanthus Maritima amide|Otanthussaeure-piperidid

C16H19NOS (273.1187284)

6-(4-methoxyphenyl)-N-(2-methylpropyl)hexa-2,4-dienamide

Indolizomycin

3-cinnamoyloxynortropan-6-ol

(2R)-2,3-epoxy-N-methylatanine

3-(1-hydroxyethyl)-6-(indol-3-ylmethyl)-2,5-diketopiperazine|cyclo(L-Trp-L-Ser-)|cyclo(L-tryptophanyl-L-seryl)|cyclo-L-Trp-L-Ser

lycojaponicumin C

lannotinidine F

SCHEMBL5928738

Alkaloid KD-1

(-)-2-Isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]chinolin-4-on|(-)-2-isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]quinolin-4-one|2.3.4.5-tetrahydro-2-isopropyl-6-methoxy-5-methyl-4-oxo-furano<3.2-c>chinolin

(-)-2-Isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]chinolin-4-on|(-)-2-isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]quinolin-4-one|2.3.4.5-tetrahydro-2-isopropyl-6-methoxy-5-methyl-4-oxo-furano<3.2-c>chinolin

Piperlonguminin

ACMC-20lw9k

(8aS,9R,11R,12aS)-6,7,8,8a,9,10,11,12-octahydro-8a-hydroxy-11-methyl-1,9-ethanobenzo[i]quinolizin-13,14-dione|huperzine F

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-2-methylpropanamide

Leu-Ala-Ala

(1S,1R)-1-hydroxy-4-(2,6-dideoxy-beta-D-xylo-hexapyranosyloxy)-2-cyclopentene-1-carboxamide

lorneamide B

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]butanamide

Pro Thr Gly

Gln Leu

Leu Gly Ala

Leu Gln

Ala Gly Leu

Ala Ile Ala

Ala Leu Gly

Pro Gly Thr

Ala Pro Ser

Thr Pro Gly

Ala Ala Ile

ACMC-20mjtp

Leu Ala Gly

Gly Leu Ala

Gly Val Val

Gly Pro Thr

oxomaritinamine

Norgalantamine

(1S,12S,14R)-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol

C16H19NO3 (273.1364864)

Norgalanthamine is a benzazepine. Norgalanthamine is a natural product found in Lycoris squamigera, Hymenocallis rotata, and other organisms with data available. N-Desmethyl Galanthamine is a metabolite of Galanthamine. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM[1][2].

Tilidine

N - Nervous system > N02 - Analgesics > N02A - Opioids CONFIDENCE standard compound; EAWAG_UCHEM_ID 3329

NVE_274.1802_16.6

CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1207

4-hydroxy-2-octylquinoline 1-oxide:Series 4 HAQ C8

Metazachlor OA

CONFIDENCE standard compound; INTERNAL_ID 2642

hexyltyrazolone

(E,E)-Piperlonguminine; AIF; CE0; CorrDec

(E,E)-Piperlonguminine; AIF; CE10; CorrDec

(E,E)-Piperlonguminine; AIF; CE30; CorrDec

(E,E)-Piperlonguminine; AIF; CE0; MS2Dec

(E,E)-Piperlonguminine; AIF; CE10; MS2Dec

(E,E)-Piperlonguminine; AIF; CE30; MS2Dec

O4-Pyridyloxobutyl-thymine

3-Pyridyloxobutyl-thymine

Ile Ala Ala

Thr Gly Pro

Ala Ala Leu

Pro Ala Ser

Ala Leu Ala

Ser Ala Pro

Pro Ser Ala

Gly Thr Pro

Val Val Gly

Ala Ser Pro

Leu Ala Ala

Ser Pro Ala

Val Gly Val

Arg Val

Val Arg

C9H15N5O5 (273.10731400000003)

4a-peroxy-tetrahydrobiopterin

Arg-val

2-(2-amino-3-methylbutanamido)-5-carbamimidamidopentanoic acid

A dipeptide formed from L-arginine and L-valine residues.

Val-arg

2-(2-amino-5-carbamimidamidopentanamido)-3-methylbutanoic acid

A dipeptide formed from L-valine and L-asparagine residues.

piperlonguminine

(2E,4E)-5-(2H-1,3-benzodioxol-5-yl)-N-(2-methylpropyl)penta-2,4-dienamide

Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4]. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4].

linalyl anthranilate

Anthranilic acid, 1, 5-dimethyl-1-vinyl-4-hexenyl ester

FEMA 3048

2-(4-methylcyclohex-3-en-1-yl)propan-2-yl 2-aminobenzoate

Piperamide-C5:1 (2E)

(2E)-5-(2H-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

1-(p-Methoxyphenyl)-5-piperidino-1-penten-3-one

(E)-1-(4-methoxyphenyl)-5-piperidin-1-ylpent-1-en-3-one;hydrochloride

CAR 5:2;O2

(3S)-3-{[(2E)-4-carboxybut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

CAR 7:0

3-(heptanoyloxy)-4-(trimethylazaniumyl)butanoate

5-TRIFLUOROMETHYLPYRIDINE-2-BORONIC ACID PINACOL ESTER

ethyl 5-tert-butyl-3-formyl-1H-indole-2-carboxylate

(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-2-((1R,4R)-4-HYDROXYCYCLOHEXYL)ACETIC ACID

2-N-BOC-Amino-3-(4-tetrahydropyranyl)-propionsaeure

3-(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-5-methyl-1,2,4-oxadiazole

C13H15N5O2 (273.122569)

5-ALLYLOXY-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXYLIC ACID BENZYL ESTER

4-[3-(1,3-BENZODIOXOL-5-YL)-1,2,4-OXADIAZOL-5-YL]PIPERIDINE

Tricyclo[3.3.1.13,7]decane, 1-(4-nitrophenyl)

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2-(TRIFLUOROMETHYL)PYRIDINE

7-Chloro-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic acid

Acridine Yellow

Acridine Yellow G

4-ALLYL-5-(4-TERT-BUTYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL

C15H19N3S (273.1299614)

BENZYL 4-OXO-2-PROPYL-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

BENZYL 2-ISOPROPYL-4-OXO-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

(2S)-2,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid

C14H11D8NO4 (273.181618824)

ISONIPECOTIC ACID, 1-ALLYL-4-PHENYL-, ETHYL ESTER

3,4-DIHYDRO-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ISOQUINOLIN-1(2H)-ONE

2-{[1-(tert-Butoxycarbonyl)-4-piperidinyl]-oxy}propanoic acid

(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethanamine

2-(1,4-dioxaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline

3-methoxycarbonylmethoxy-piperidine-1-carboxylic acid tert-butyl ester

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine

Benzenamine,N-phenyl-4-(2-phenyldiazenyl)-

C18H15N3 (273.126591)

9-((tert-Butoxycarbonyl)amino)nonanoic acid

(S)-MORPHOLINE-3,4-DICARBOXYLICACID4-TERT-BUTYLESTER

5-Trifluoromethylpyridine-3-boronic acid pinacol ester

1-(5-Nitroquinolin-6-yl)piperidin-4-ol

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopropanamine

(S)-tert-Butyl 3-(2-ethoxy-2-oxoethyl)morpholine-4-carboxylate

(R)-TERT-BUTYL 4-(4-HYDROXYBUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

4-(2-cyclohexylethylamino)-2-nitrobenzonitrile

1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone

5-Cyclohexyl-3-(3-nitrophenyl)-1,2,4-oxadiazole

2-Trifluoromethylpyridine-4-boronic acid pinacol ester

Naphazoline nitrate

C14H21ClFNO (273.12956180000003)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Naphazoline (Naphthazoline) nitrate is an α-adrenergic receptor agonist. Naphazoline nitrate reduces vascular hyperpermeability and promotes vasoconstriction. Naphazoline nitrate reduces the levels of inflammatory factors (TNF-α, IL-1β and IL-6), cytokines (IFN-γ and IL-4), IgE, GMCSF, and NGF。Naphazoline nitrate can be used for non-bacterial conjunctivitis research[1][2].

(1R,4R)-1-(AMINOMETHYL)-4-(4-FLUOROBENZYL)CYCLOHEXANOL HYDROCHLORIDE

3-(Boc-amino)-3-(4-tetrahydropyranyl)propanoic Acid

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PYRROLIDINE

N-BIS(TERT-BUTYLPROPIONATE)AMINE

Benzenemethanamine,N-phenyl-N-(phenylmethyl)-

C17H20ClN (273.12841900000006)

(R)-2-(diphenylmethyl)pyrrolidine hydrochloride

2-(2-PYRIDIN-2-YL-1H-INDOL-3-YL)ETHANAMINE MONOHYDROCHLORIDE

2-(2-PYRIDIN-3-YL-1H-INDOL-3-YL)ETHANAMINE MONOHYDROCHLORIDE

2-(2-PYRIDIN-4-YL-1H-INDOL-3-YL)ETHANAMINE MONOHYDROCHLORIDE

2-{2-[3-(trifluoromethyl)phenoxy]ethyl}piperidine

C14H18F3NO (273.1340414)

1-(Triisopropylsilyl)-1H-indole

C17H27NSi (273.1912662)

tert-butyl 4,4-bis(2-hydroxyethyl)piperidine-1-carboxylate

1-BOC-4-(METHOXYCARBONYL)PYRROLIDINE-3-CARBOXYLIC ACID

6-PHENETHYLCARBAMOYL-CYCLOHEX-3-ENECARBOXYLIC ACID

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate

ETHYL 2-ISOPROPOXY-4-METHOXYBENZIMIDATE HYDROCHLORIDE

C17H20ClN (273.12841900000006)

4,4-Diphenylpiperidine hydrochloride

tert-Butyl 4-methoxynaphthalen-2-ylcarbamate

2-Chloro-5-phenyl-4-(piperidin-1-yl)pyrimidine

1-Methyl-1-propylpyrrolidinium hexafluorophosphate

C8H18F6NP (273.108099)

2-Fluoro-4-(trans-4-pentylcyclohexyl)-benzonitrile

C18H24FN (273.1892676)

5-chloro-2-phenyl-4-piperidin-1-ylpyrimidine

1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethanamine

5-Cyclohexyl-3-(4-nitrophenyl)-1,2,4-oxadiazole

1-Piperidinecarboxylic acid, 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-, ethyl ester

3-(3-CYCLOPROPYL-1-OXOPROPYL)-4(R)-(1-PHENYLMETHYL)-2-OXAZOLIDINONE

2-Amino-8-benzyl-2,8-diazaspiro[4.5]decane-1,3-dione

4-Methyl 1-(2-methyl-2-propanyl) 4-methoxy-1,4-piperidinedicarbox ylate

N,N-Bis(M-tolyl)benzenaMine

ethyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,prop-2-enoic acid

tert-butyl N-[2-(2,4-difluorophenyl)-2-hydroxyethyl]carbamate

C13H17F2NO3 (273.1176436)

4-DIMETHYLAMINOMETHYL-THIOPHENE-2-CARBALDEHYDE

C14H21Cl2N (273.1050966)

4,4-Dimethyltriphenylamine

3,4-Dimethyltriphenylamine

3,5-dimethyl-N-phenylaniline

4-Ethylphenyl 4-trans-propylcyclohexylcarboxylate

C18H25O2- (273.185445)

3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)aniline

C13H18F3N3 (273.1452744)

2-CARBOXYMETHYL-5,5-DIMETHYL-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER

(R)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine

8-Hydroxy-1,1,7,7-tetramethyljulolidine-9-carboxaldehyde

N-Cbz-9-azabicyclo[3.3.1]nonan-3-one

3-Amino-6-(4-methylphenyl)pyrazinecarboxylicacidethylester-4-oxide

Oxaflozane

C14H18F3NO (273.1340414)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants

(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate

2-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]-1,3,4-oxadiazole

C13H16BN3O3 (273.1284656)

Propanamide, 2-methyl-N-[2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]

Ethyl N-Boc-5-hydroxypiperidine-3-carboxylate

4-(N,N-Diphenylamino)benzaldehyde

C19H15NO (273.115358)

1-[3-(4-p-tolyl-piperazin-1-yl)-azetidin-1-yl]-ethanone

6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-qu inolin-2-one

(2S)-1-TERT-BUTYL 2-ETHYL 5-METHOXYPYRROLIDINE-1,2-DICARBOXYLATE

1-(1-benzylpiperidin-4-yl)-1,3-diazinan-2-one

C11H14F3N5 (273.12012400000003)

2-(TERT-BUTYL)-7-HYDRAZINO-5-(TRIFLUOROMETHYL)PYRAZOLO[1,5-A]PYRIMIDINE

5-(4-hydroxyphenyl)-5-phenyl-d5-hydantoin-15n2

C15H7D5N2O3 (273.11617409)

4-Trifluoromethyl-pyridine-3-boronic acid

5-diethylaminomethyl-2-phenyl-furan-3-carboxylic acid

(N-AcrylaMidophenyl)boronic acid pinacol ester

(3aS,5R,6S,6aS)-[6-hydroxy-2,2-dimethyltetrahydrofuro[3,2-d][1,3]dioxol-5-yl]-(morpholino)methanone

6-(trifluoromethyl)pyridine-2-boronic acid pinacol ester

[2-(3,4-DIFLUOROPHENYL)-2-HYDROXYETHYL]-CARBAMIC ACID 1,1-DIMETHYLETHYL ESTER

C13H17F2NO3 (273.1176436)

Mavacamten

C - Cardiovascular system > C01 - Cardiac therapy

rac Viloxazine-d5 Hydrochloride

7,7-azanediyldiheptanoic acid

N-Acetyl Retigabine

C15H16FN3O (273.1277338)

Viloxazine hydrochloride

2-[(2-ethoxyphenoxy)methyl]morpholine hydrochloride

D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one

6-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

4-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

7-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

2-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline

(2-AMINOETHOXY)DIPHENYLBORANE

C12H21BClNO3 (273.1302936)

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylamide

D-ASPARTIC ACID, N-[(1,1-DIMETHYLETHOXY)CARBONYL]-, 4-(2-PROPENYL) ESTER

4-[2-(Methyl-2-pyridinyl)amino]ethoxyl nitrobenzene

2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE

2-(Benzyloxy)-2-(2-naphthyl)acetonitrile

C19H15NO (273.115358)

3-(4-Benzyloxyphenoxy)-2-hydroxypropanamine

1-[(tert-butoxy)carbonyl]-3-(ethoxycarbonyl)azetidine-3-carboxylic acid

5-Methoxy-1H-indole-2-boronic acid pinacol ester

4-[(6-nitroquinolin-2-yl)methyl]morpholine

1-[3-amino-5-[4-(tert-butyl)phenyl]-2-thienyl]ethan-1-one

C16H19NOS (273.1187284)

Ac-Ala-Ala-Ala-OH

2,4-dimethyl-N,N-diphenylaniline

2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethanamine

C13H18F3N3 (273.1452744)

boc-asp(oall)-oh

4-pyren-1-ylbutan-1-amine

4-(4-Methylpiperazin-1-ylmethyl)-3-trifluoromethylaniline

C13H18F3N3 (273.1452744)

2-oxo-7-aza-spiro[3.5]nonane-7-carboxylic acid benzyl ester

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

Dextilidine

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids

s-Triazine, 1,2-dihydro-1-(p-butylphenyl)-4,6-diamino-2,2-dimethyl-

C15H23N5 (273.1953358)

Desmethylcyproheptadine

Tilidine, (-)-

Tropanserin

C17H20ClN (273.12841900000006)

C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Tropanserin is a serotoninergic active compound, as well as a 5HT3 receptor antagonist. Tropanserin modulates Cardio-respiratory reflex effects of an exogenous serotonin challenge[1].

Etifelmine hydrochloride

L-Alanine, L-alanyl-L-leucyl-

(E)-1-(4-methylphenyl)-3-quinolin-6-ylprop-2-en-1-one

C19H15NO (273.115358)

L-Alanyl-L-alanyl-L-leucine

1-Butyl-3-(2-hydroxyethylamino)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile

5-Dihydrobenzofuranpyrovalerone

N-(2-oxolanylmethyl)-3-(1-tetrazolyl)benzamide

C13H15N5O2 (273.122569)

Glycyl-L-valyl-L-valine

Evaclin; Evadol; Isodianidylethanolamine; LC 2

5-(1,3-Benzodioxol-5-yl)-N,N-diethyl-2,4-pentadienamide

Naphthalen-1-yl methyl(trimethylsilyl)carbamate

C15H19NO2Si (273.1184994)

[(2-Ethoxy-1-naphthoyl)amino]methylboronic acid

C14H16BNO4 (273.1172326)

N-{[(2s,3s)-3-(Ethoxycarbonyl)oxiran-2-Yl]carbonyl}-L-Isoleucine

3-Amino-3-benzyl-9-carboxamide[4.3.0]bicyclo-1,6-diazanonan-2-one

5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid

Prodolic acid

Pyrano[3,4-b]indole-1-aceticacid, 1,3,4,9-tetrahydro-1-propyl-